BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23305738)

  • 21. Low Rap1-interacting factor 1 and sirtuin 6 expression predict poor outcome in radiotherapy-treated Hodgkin lymphoma patients.
    Bur H; Haapasaari KM; Turpeenniemi-Hujanen T; Kuittinen O; Auvinen P; Marin K; Soini Y; Karihtala P
    Leuk Lymphoma; 2018 Mar; 59(3):679-689. PubMed ID: 28786706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
    Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Viviani S; Bonfante V; Nadali G; Herling M; Angelopoulou MK; Giardini R; Chilosi M; Kittas C; McDonnell TJ; Bonadonna G; Gianni AM; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Blood; 2002 Dec; 100(12):3935-41. PubMed ID: 12433696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes.
    Audard V; Zhang SY; Copie-Bergman C; Rucker-Martin C; Ory V; Candelier M; Baia M; Lang P; Pawlak A; Sahali D
    Blood; 2010 May; 115(18):3756-62. PubMed ID: 20200355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Trümper LH; von Bonin F; Kapp U; Patterson B; Snow BE; Mak TW
    Blood; 2001 Jan; 97(1):250-5. PubMed ID: 11133768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.
    Quesada AE; Assylbekova B; Jabcuga CE; Zhang R; Covinsky M; Rios A; Nguyen ND; Brown RE
    Int J Clin Exp Pathol; 2015; 8(10):13241-8. PubMed ID: 26722524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MET and MST1R as prognostic factors for classical Hodgkin's lymphoma.
    Wha Koh Y; Park C; Hyun Yoon D; Suh C; Huh J
    Mod Pathol; 2013 Sep; 26(9):1172-82. PubMed ID: 23558571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Checkpoint CD47 expression in classical Hodgkin lymphoma.
    Gholiha AR; Hollander P; Löf L; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini RM; Enblad G
    Br J Haematol; 2022 Jun; 197(5):580-589. PubMed ID: 35301709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease.
    Seitz V; Hummel M; Marafioti T; Anagnostopoulos I; Assaf C; Stein H
    Blood; 2000 May; 95(10):3020-4. PubMed ID: 10807764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The histologic, immunohistochemical, and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell/B-cell antigen expression.
    Liang K; Wang J; Wang Y; Zhou Z; Ge S; Mei S; Li H; Jing X; Zhang C
    Hum Pathol; 2019 Feb; 84():309-320. PubMed ID: 30339972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
    Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
    Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
    Karube K; Niino D; Kimura Y; Ohshima K
    Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on the origin of H/RS cell and their biological behavior in Hodgkin lymphoma by using multiple mark techniques].
    Wang JF; Xi YF; Wang LX; Yin WD; Zhang JW; Gong FC
    Zhonghua Xue Ye Xue Za Zhi; 2004 Oct; 25(10):579-82. PubMed ID: 15634588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus-positive Hodgkin/Reed-Sternberg-like B cell in non-hodgkin lymphoma: nucleotide sequence of the amplified immunoglobulin heavy-chain variable region gene by the single-cell polymerase chain reaction technique.
    Nakamura N; Mori N; Ohshima K; Kuze T; Hashimoto Y; Sasaki Y; Shirakawa A; Sato M; Abe M
    Diagn Mol Pathol; 2002 Jun; 11(2):83-9. PubMed ID: 12045711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation.
    Bose S; Starczynski J; Chukwuma M; Baumforth K; Wei W; Morgan S; Byrd P; Ying J; Grundy R; Mann JR; Tao Q; Taylor AM; Murray PG; Stankovic T
    J Pathol; 2007 Nov; 213(3):329-36. PubMed ID: 17876757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription.
    Marafioti T; Hummel M; Foss HD; Laumen H; Korbjuhn P; Anagnostopoulos I; Lammert H; Demel G; Theil J; Wirth T; Stein H
    Blood; 2000 Feb; 95(4):1443-50. PubMed ID: 10666223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classical Hodgkin Lymphoma With Aberrant CD8 Expression: A Clinicopathologic Study of Five Cases.
    Mirzamani N; Zhang X; Brody J; Spitzer SG; Sen F; Hsu P
    Int J Surg Pathol; 2019 Apr; 27(2):166-173. PubMed ID: 30058423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
    Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
    Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of CD4+CD25 +FOXP3+ regulatory T cells correlates with Epstein-Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil.
    Assis MC; Campos AH; Oliveira JS; Soares FA; Silva JM; Silva PB; Penna AD; Souza EM; Baiocchi OC
    Med Oncol; 2012 Dec; 29(5):3614-9. PubMed ID: 22791223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.